By GREGORY ZELLER
Look out, coronavirus – Applied DNA is coming for you.
Adding to its growing portfolio of cutting-edge Polymerase Chain Reaction-based projects, Stony Brook-based Applied DNA Sciences is expanding its Joint Development Agreement with Italian R&D company Takis Biotech, with the headline-making 2019-nCoV in their sights.
 | Linear time: The world won’t see an effective vaccine against 2019-nCoV for months — or maybe sooner, thanks to Applied DNA Sciences. |
Already hot on the trail of new cancer vaccines, the partners will now work on a “linear DNA” vaccine against the dreaded Wuhan, China-based illness that’s sweeping the globe.